KOPRANNSEKopran Limited· PharmaceuticalsMediumNegative
Announced Tue, 17 Mar · 15:51 IST

Kopran Limited has informed the Exchange regarding Resignation of Mr. Adarsh Somani as Non- Executive Director of the company w.e.f. March 17, 2026.

Management Changes View source PDF

KOPRAN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.3%1-day move
₹113.21
prior close
₹113.60
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.1+0.8+1.8+1.9+1.3+4.2-0.3+1.8+8.2-3.8+38.6+36.9+44.9+63.3
Up moveDown movePending
AI summary

Mr. Adarsh Somani (DIN: 00192609) has resigned as Non-Executive Non-Independent Director of Kopran Limited with effect from March 17, 2026. He has also stepped down from the Stakeholder Relationship Committee, Risk Management Committee, and Corporate Affairs Committee. The resignation is linked to a Memorandum of Family Settlement dated September 1, 2025, executed among the promoters of the company regarding shareholding and directorship across various listed and unlisted companies. He held no shares in the company at the time of resignation.

Likely market impact

This is a promoter-family-led board change arising from a family settlement rather than a performance or governance issue. The immediate impact on shareholders is limited, but it signals an internal restructuring of promoter shareholding and directorship arrangements that investors should monitor for further changes in board composition or shareholding patterns.